Pertussis: persistent pathogen, imperfect vaccines
- 1 February 2003
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 2 (1) , 113-127
- https://doi.org/10.1586/14760584.2.1.113
Abstract
Routine use of pertussis vaccines has diminished the incidence of this disease but has not eliminated the pathogen. Pertussis remains a significant cause of disease in both very young infants and in the adolescent and adult populations. Acellular pertussis vaccines have fewer adverse reactions compared with whole-cell pertussis vaccines. Although efficacious against severe disease, current vaccines may not be as efficacious against milder forms of infection. New methodologies for understanding disease pathogenesis, immune responses and vaccine development are needed to effectively interrupt continued transmission of this pathogen.Keywords
This publication has 36 references indexed in Scilit:
- Pertussis Is a Frequent Cause of Prolonged Cough Illness in Adults and AdolescentsClinical Infectious Diseases, 2001
- Mechanisms of bordetella pathogenesisFrontiers in Bioscience-Landmark, 2001
- Neutralizing Antibodies to Adenylate Cyclase Toxin Promote Phagocytosis ofBordetella pertussisby Human NeutrophilsInfection and Immunity, 2000
- Frequency of Serological Evidence of Bordetella Infections and Mixed Infections with other Respiratory Pathogens in University Students with Cough IllnessesClinical Infectious Diseases, 2000
- Failure of Physicians to Consider the Diagnosis of Pertussis in ChildrenClinical Infectious Diseases, 1999
- Role of pertussis toxin in causing symptoms ofBordetella parapertussis infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- The return of pertussisThe Pediatric Infectious Disease Journal, 1987
- Antimicrobial treatment of pertussisThe Journal of Pediatrics, 1969
- A Study of Experimental Pertussis in the Young RatPublic Health Reports (1896-1970), 1939
- Pertussis in adultsThe Journal of Pediatrics, 1934